Comparison between Clinitech Laboratory IPO and VVIP Infratech IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while VVIP Infratech IPO is a SME Bookbuilding proposed to list at BSE SME.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Share India Capital Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Share India Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the VVIP Infratech IPO is up to ₹58.07 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of VVIP Infratech IPO is ₹93.00 per share.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | |
| Issue Price (Upper) | ₹93.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹93.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 5,71,200 shares | 62,43,600 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹58.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 62,43,600 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹58.07 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while VVIP Infratech IPO opens on Jul 23, 2024. The closing date of Clinitech Laboratory IPO and VVIP Infratech IPO is Jul 29, 2024, and Jul 25, 2024, respectively.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |
|---|---|---|
| Anchor Bid Date | Jul 22, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 23, 2024 |
| Issue Close | Jul 29, 2024 | Jul 25, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 26, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 29, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 29, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Jul 30, 2024 |
| Anchor Lockin End date 1 | Aug 25, 2024 | |
| Anchor Lockin End date 2 | Oct 24, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to VVIP Infratech IPO P/E ratio of 8.26.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| VVIP Infratech Limited Financial Information (Restated Consolidated)VVIP Infratech Limited's revenue increased by 35.77% and profit after tax (PAT) rose by 52.56% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.63 | 92.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 8.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹232.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.36% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 0.40 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹11.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 18.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in VVIP Infratech IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 12,48,000 shares in VVIP Infratech IPO.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |
|---|---|---|
| Anchor Investor Reserveration | 18,72,000 shares | |
| Market Maker Reserveration | 31,200 shares | 3,38,400 shares |
| QIB | 12,48,000 shares | |
| NII | 2,85,600 shares | 9,37,200 shares |
| RII | 2,85,600 shares | 21,86,400 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 62,43,600 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas VVIP Infratech IPO subscribed 236.92x.
| Clinitech Laboratory IPO | VVIP Infratech IPO | |
|---|---|---|
| QIB (times) | 168.45x | |
| NII (times) | 23.28x | 456.82x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 181.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 236.92x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
